Related Experiment Video
Updated: Dec 14, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Potential Risk of Hypoglycemia in Patients with Heart Failure
Yasushi Teshima1, Ryosuke Shiga1, Shotaro Saito1
1Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University.
Insights
Patients with chronic heart failure experience prolonged hypoglycemia, even without diabetes treatment. This study highlights the risk of low blood glucose in heart failure patients, suggesting malabsorption as a potential cause.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Disorders
Background:
- Glucose metabolism alterations in chronic heart failure are not well understood.
- Previous research has not focused on sequential interstitial glucose changes in non-diabetic heart failure patients.
Purpose of the Study:
- To investigate sequential interstitial glucose concentration changes in patients with chronic heart failure (CHF).
- To compare glucose profiles between CHF patients and those with chronic heart disease but no heart failure, excluding antidiabetic therapy.
Main Methods:
- Utilized a continuous glucose monitoring device (FreeStyle Libre Pro) for 1-week monitoring.
- Enrolled 11 patients with CHF (Heart failure (+)) and 7 controls (Heart failure (-)).
- Analyzed interstitial glucose levels, including average, peak, duration of hyperglycemia (≥ 140 mg/dL), and hypoglycemia (< 80 mg/dL).
Main Results:
- No significant differences in average glucose, peak values, or hyperglycemia duration between groups.
- Significantly longer duration and lower trough values of hypoglycemia in the Heart failure (+) group.
- Prolonged hypoglycemia observed predominantly from midnight to morning in Heart failure (+) patients, often without subjective symptoms.
Conclusions:
- Patients with chronic heart failure are at increased risk of hypoglycemia, independent of antidiabetic treatment.
- Malabsorption is a potential contributing mechanism for hypoglycemia in this population.
- Continuous glucose monitoring reveals significant nocturnal hypoglycemia in heart failure patients.
Abstract:
The properties of glucose changes in patients with chronic heart failure remain elusive. In the present study, we investigated the sequential changes of interstitial glucose concentrations in patients with chronic heart failure and heart disease who were not undergoing antidiabetic therapy.A glucose monitoring device (FreeStyle Libre Pro) was attached to the backside of an upper arm and the interstitial glucose concentration was monitored every 15 minutes for 1 week. Eleven patients with chronic heart failure (Heart failure (+) ) and 7 patients with chronic heart diseases but not with heart failure (Heart failure (-) ) were enrolled. The average level and peak value of interstitial glucose concentrations, and the duration of hyperglycemia (≥ 140 mg/dL) were not significantly different between Heart failure (+) and Heart failure (-). The duration of hypoglycemia (< 80 mg/dL) was significantly longer and the trough value was significantly lower in Heart failure (+) compared with Heart failure (-). Most of the patients in Heart failure (+) were exposed to a long duration of hypoglycemia from midnight to morning. Importantly, none of the patients who showed hypoglycemia complained of any subjective symptoms during hypoglycemia. Malabsorption may be one of the mechanisms of hypoglycemia.In summary, patients with chronic heart failure are at risk of developing hypoglycemia even if they do not undergo any antidiabetic therapy.
More Related Videos
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Hypoglycemia and Glucagon
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management